| |
| |
|
| Insider
Information: |
Coiante Scott M |
| Relationship: |
SVP, Chief Financial O... |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
165,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,149 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
165,145 |
|
|
| Total
Value |
$4,149 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agile Therapeutics Inc |
AGRX |
Chief Financial Officer |
2023-10-03 |
20,080 |
|
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
SVP, Chief Financial O... |
2022-07-28 |
145,065 |
2019-10-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,080 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80 |
|
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• – – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,800 |
145,065 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• • – |
2022-06-03 |
4 |
D |
$0.81 |
$28,404 |
D/D |
(35,284) |
84,265 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
42,900 |
119,549 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• – – |
2022-02-25 |
4 |
D |
$1.74 |
$25,782 |
D/D |
(14,817) |
76,649 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
96,500 |
99,000 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Financial Officer |
• • – |
2019-10-07 |
4 |
B |
$15.00 |
$37,500 |
D/D |
2,500 |
2,500 |
0.01 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
48,256 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,070 |
30,756 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-01-25 |
4 |
D |
$3.32 |
$22,420 |
D/D |
(6,753) |
14,686 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
21,439 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,939 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
